CCG
ALXN

Cypress Capital Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Cypress Capital Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,102
Closed -$485K – 294
2020
Q4 		$485K Buy
3,102
+1,020
+49% +$131K 0.07% 200
2020
Q3 		$238K Buy
2,082
+47
+2% +$5.07K 0.04% 233
2020
Q2 		$228K Buy
+2,035
New +$216K 0.04% 227
2016
Q1 		– Sell
-2,333
Closed -$445K – 186
2015
Q4 		$445K Hold
2,333
– – 0.11% 133
2015
Q3 		$365K Hold
2,333
– – 0.09% 151
2015
Q2 		$422K Sell
2,333
-407
-15% -$70.2K 0.1% 145
2015
Q1 		$475K Buy
2,740
+407
+17% +$73.7K 0.11% 145
2014
Q4 		$432K Hold
2,333
– – 0.1% 148
2014
Q3 		$387K Hold
2,333
– – 0.09% 145
2014
Q2 		$365K Hold
2,333
– – 0.09% 156
2014
Q1 		$355K Hold
2,333
– – 0.09% 155
2013
Q4 		$310K Hold
2,333
– – 0.08% 155
2013
Q3 		$271K Hold
2,333
– – 0.07% 162
2013
Q2 		$215K Buy
+2,333
New +$225K 0.04% 204

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return